QuantaMatrix Company Description

QuantaMatrix Inc. operates as an in-vitro diagnostics company in South Korea.

Its products include dRAST, a direct and rapid antimicrobial susceptibility test for treating sepsis that provides MIC-based phenotypic antimicrobial susceptibility testing direct from positive blood culture; QDST, a rapid phenotypic drug susceptibility testing system for tuberculosis; QPLEX Alz plus assay, an early diagnosis kit for Alzheimer's disease; and Quanti9 and QuantiGal, a prognostic prediction kit for cardiovascular diseases.

QuantaMatrix Inc. was founded in 2010 and is based in Seoul, South Korea.

QuantaMatrix Inc.

Country	South Korea
Founded	2010
Industry	Electromedical and Electrotherapeutic Apparatus
CEO	Sung Hoon Kwon

Contact Details

Address: Bldg.B, BYC HIGHCITY, 131 Seoul, 08506 South Korea
Phone	82 2 763 8820
Website	quantamatrix.com

Stock Details

Ticker Symbol	317690
Exchange	KOSDAQ
Fiscal Year	January - December
Reporting Currency	KRW
SIC Code	3845

Key Executives

Name	Position
Sung Hoon Kwon	Chief Executive Officer